Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, AN2 Therapeutics Inc (NASDAQ: ANTX) closed at $2.55 down -0.39% from its previous closing price of $2.56. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 1.18 million shares were traded. ANTX stock price reached its highest trading level at $2.7311 during the session, while it also had its lowest trading level at $2.376.
Ratios:
For a deeper understanding of AN2 Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.91 and its Current Ratio is at 10.91. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 02, 2024, JMP Securities Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $6.
Leerink Partners Downgraded its Outperform to Market Perform on February 13, 2024, whereas the target price for the stock was revised from $23 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 18 ’24 when Zakrzewski Joseph S sold 100,000 shares for $19.11 per share. The transaction valued at 1,911,410 led to the insider holds 405,880 shares of the business.
Aziz Kabeer sold 100,000 shares of ANTX for $1,965,000 on Jan 16 ’24. The Director now owns 377,542 shares after completing the transaction at $19.65 per share. On Jan 16 ’24, another insider, Adjuvant Global Health Technol, who serves as the 10% Owner of the company, sold 84,093 shares for $19.65 each. As a result, the insider received 1,652,427 and left with 1,995,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANTX now has a Market Capitalization of 76063952 and an Enterprise Value of -37847656.
Stock Price History:
Over the past 52 weeks, ANTX has reached a high of $22.22, while it has fallen to a 52-week low of $1.91. The 50-Day Moving Average of the stock is 10.57%, while the 200-Day Moving Average is calculated to be -71.72%.
Shares Statistics:
For the past three months, ANTX has traded an average of 138.66K shares per day and 186520 over the past ten days. A total of 29.74M shares are outstanding, with a floating share count of 19.98M. Insiders hold about 33.03% of the company’s shares, while institutions hold 59.29% stake in the company. Shares short for ANTX as of 1721001600 were 690674 with a Short Ratio of 4.98, compared to 1718323200 on 707266. Therefore, it implies a Short% of Shares Outstanding of 690674 and a Short% of Float of 3.5900000000000003.
